BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33091796)

  • 1. Adaptive SBRT by 1.5 T MR-linac for prostate cancer: On the accuracy of dose delivery in view of the prolonged session time.
    Ruggieri R; Rigo M; Naccarato S; Gurrera D; Figlia V; Mazzola R; Ricchetti F; Nicosia L; Giaj-Levra N; Cuccia F; Vitale C; Stavreva N; Pressyanov DS; Stavrev P; Pellegrini R; Alongi F
    Phys Med; 2020 Dec; 80():34-41. PubMed ID: 33091796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of adaptive planning in margin-reduced, MRI-guided stereotactic body radiotherapy to the prostate bed following radical prostatectomy: Post-hoc analysis of a phase II clinical trial.
    Nikitas J; Smith LM; Gao Y; Ma TM; Sachdeva A; Yoon SM; Jiang T; Low DA; Ballas LK; Steinberg ML; Cao M; Kishan AU
    Radiother Oncol; 2023 Jun; 183():109631. PubMed ID: 36934894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dosimetric error due to uncorrected tumor rotation during real-time adaptive prostate stereotactic body radiation therapy.
    Sengupta C; Skouboe S; Ravkilde T; Poulsen PR; Nguyen DT; Greer PB; Moodie T; Hardcastle N; Hayden AJ; Turner S; Siva S; Tai KH; Martin J; Booth JT; O'Brien R; Keall PJ
    Med Phys; 2023 Jan; 50(1):20-29. PubMed ID: 36354288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric effects of adaptive prostate cancer radiotherapy in an MR-linac workflow.
    Mannerberg A; Persson E; Jonsson J; Gustafsson CJ; Gunnlaugsson A; Olsson LE; Ceberg S
    Radiat Oncol; 2020 Jul; 15(1):168. PubMed ID: 32650811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SBRT focal dose intensification using an MR-Linac adaptive planning for intermediate-risk prostate cancer: An analysis of the dosimetric impact of intra-fractional organ changes.
    Brennan VS; Burleson S; Kostrzewa C; Godoy Scripes P; Subashi E; Zhang Z; Tyagi N; Zelefsky MJ
    Radiother Oncol; 2023 Feb; 179():109441. PubMed ID: 36549340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical application of a sub-fractionation workflow for intrafraction re-planning during prostate radiotherapy treatment on a 1.5 Tesla MR-Linac: A practical method to mitigate intrafraction motion.
    Willigenburg T; Zachiu C; Bol GH; de Groot-van Beugel EN; Lagendijk JJW; van der Voort van Zyp JRN; Raaymakers BW; de Boer JCJ
    Radiother Oncol; 2022 Nov; 176():25-30. PubMed ID: 36113777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy.
    Cuccia F; Mazzola R; Nicosia L; Figlia V; Giaj-Levra N; Ricchetti F; Rigo M; Vitale C; Mantoan B; De Simone A; Sicignano G; Ruggieri R; Cavalleri S; Alongi F
    Radiat Oncol; 2020 Jul; 15(1):178. PubMed ID: 32698843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric and deformation effects of image-guided interventions during stereotactic body radiation therapy of the prostate using an endorectal balloon.
    Jones BL; Gan G; Diot Q; Kavanagh B; Timmerman RD; Miften M
    Med Phys; 2012 Jun; 39(6):3080-8. PubMed ID: 22755693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gating has a negligible impact on dose delivered in MRI-guided online adaptive radiotherapy of prostate cancer.
    Wahlstedt I; Andratschke N; Behrens CP; Ehrbar S; Gabryś HS; Schüler HG; Guckenberger M; Smith AG; Tanadini-Lang S; Tascón-Vidarte JD; Vogelius IR; van Timmeren JE
    Radiother Oncol; 2022 May; 170():205-212. PubMed ID: 35351536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying the impact of SpaceOAR hydrogel on inter-fractional rectal and bladder dose during 0.35 T MR-guided prostate adaptive radiotherapy.
    Farjam R; Mahase SS; Chen SL; Coonce M; Pennell RT; Fecteau R; Chughtai B; Dewyngaert JK; Kang J; Ch Formenti S; Nagar H
    J Appl Clin Med Phys; 2021 Sep; 22(9):49-58. PubMed ID: 34342134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pelvic organ motion and dosimetric implications during horizontal patient rotation for prostate radiation therapy.
    Buckley JG; Dowling JA; Sidhom M; Liney GP; Rai R; Metcalfe PE; Holloway LC; Keall PJ
    Med Phys; 2021 Jan; 48(1):397-413. PubMed ID: 33151543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic body radiotherapy using a hydrogel spacer for localized prostate cancer: A dosimetric comparison between tomotherapy with the newly-developed tumor-tracking system and cyberknife.
    Manabe Y; Hashimoto S; Mukouyama H; Shibamoto Y
    J Appl Clin Med Phys; 2021 Oct; 22(10):66-72. PubMed ID: 34415658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated Planning for Prostate Stereotactic Body Radiation Therapy on the 1.5 T MR-Linac.
    Naccarato S; Rigo M; Pellegrini R; Voet P; Akhiat H; Gurrera D; De Simone A; Sicignano G; Mazzola R; Figlia V; Ricchetti F; Nicosia L; Giaj-Levra N; Cuccia F; Stavreva N; Pressyanov DS; Stavrev P; Alongi F; Ruggieri R
    Adv Radiat Oncol; 2022; 7(3):100865. PubMed ID: 35198836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daily dosimetric variation between image-guided volumetric modulated arc radiotherapy and MR-guided daily adaptive radiotherapy for prostate cancer stereotactic body radiotherapy.
    Nicosia L; Sicignano G; Rigo M; Figlia V; Cuccia F; De Simone A; Giaj-Levra N; Mazzola R; Naccarato S; Ricchetti F; Vitale C; Ruggieri R; Alongi F
    Acta Oncol; 2021 Feb; 60(2):215-221. PubMed ID: 32945701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate bed and organ-at-risk deformation: Prospective volumetric and dosimetric data from a phase II trial of stereotactic body radiotherapy after radical prostatectomy.
    Yoon S; Cao M; Aghdam N; Shabsovich D; Kahlon S; Ballas L; Collins S; Steinberg ML; Kishan AU
    Radiother Oncol; 2020 Jul; 148():44-50. PubMed ID: 32311600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric and radiobiological consequences of computed tomography-guided adaptive strategies for intensity modulated radiation therapy of the prostate.
    Battista JJ; Johnson C; Turnbull D; Kempe J; Bzdusek K; Van Dyk J; Bauman G
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):874-80. PubMed ID: 23978708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric feasibility of stereotactic irradiation of primary prostate cancer at 5x9 Gy with a method of urethral sparing.
    Benhmida S; Beneux A; Udrescu C; Rouviere O; Horn S; Enachescu C; Lapierre A; Chapet O
    Br J Radiol; 2021 Nov; 94(1127):20210142. PubMed ID: 34283647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of online/offline image guidance/adaptation approaches for prostate cancer radiation therapy.
    Qin A; Sun Y; Liang J; Yan D
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1026-33. PubMed ID: 25832693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single institution's dosimetry and IGRT analysis of prostate SBRT.
    Wu QJ; Li T; Yuan L; Yin FF; Lee WR
    Radiat Oncol; 2013 Sep; 8():215. PubMed ID: 24034234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer.
    Schaule J; Chamberlain M; Wilke L; Baumgartl M; Krayenbühl J; Zamburlini M; Mayinger M; Andratschke N; Tanadini-Lang S; Guckenberger M
    Radiat Oncol; 2021 Sep; 16(1):189. PubMed ID: 34565439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.